Dental Practice Valuation Multiples in 2026: What Your Practice Is Actually Worth

The single question I get from dental practice owners more than any other is simple: What is my practice worth?

The honest answer is that dental practice valuation multiples in 2026 are not random numbers — they are a score. They reflect how legible, scalable, and de-risked your practice looks to a buyer who has underwritten hundreds of practices and is deploying capital against a disciplined investment thesis.

Before I sold Afinia Dental Group to private equity in 2021, I spent years building a practice that would score well on the criteria buyers actually use — not the criteria most dental consultants talk about. I have sat on both sides of the table: the operator building value and the seller receiving offers. This guide explains what the 2026 dental M&A market is actually paying, what drives the spread between a 3x and a 14x dental EBITDA multiple, and the specific moves that shift your practice up the range.

Contrarian take: Most dentists obsess over the multiple. They shouldn't. Adjusted EBITDA is the number that matters. A 6x multiple on $800K of adjusted EBITDA beats a 9x multiple on $400K of adjusted EBITDA every single time — and the work required to grow EBITDA is almost always a better use of 12–24 months than the work required to squeeze an extra turn out of a buyer.

The Shift From Collections to EBITDA — Why the Old Math No Longer Works

For decades, dental practices were valued as a percentage of annual collections — typically 60% to 80% for a general practice. That methodology is effectively dead in any transaction involving a DSO or private equity buyer.

Modern DSO acquisition valuation is anchored to a multiple of adjusted EBITDA — earnings before interest, taxes, depreciation, and amortization, with the owner's compensation normalized to a market-rate associate wage. The logic is straightforward: collections tell a buyer how much money came in the door. Adjusted EBITDA tells a buyer how much of it actually survives to cash flow — after paying every operating expense, including a fair clinical wage.

The normalization step is critical and routinely misunderstood. If you are paying yourself $650,000 as an owner-operator and a comparable associate would cost $280,000, that $370,000 delta is added back to EBITDA. If you are running personal expenses through the practice — vehicle, phone, travel, continuing education beyond what an associate would receive — those get added back too. The resulting number is adjusted EBITDA, and it is what buyers multiply.

This shift matters enormously for practice owners who have been told their practice is "worth 70% of collections." Consider two practices: Practice A has $2.0M collections and $400K adjusted EBITDA. Practice B has $1.8M collections and $700K adjusted EBITDA. Under the old collections methodology, Practice A looks more valuable. Under the EBITDA methodology every DSO and PE buyer uses in 2026, Practice B is worth roughly 75% more.

Collections are a vanity metric. Adjusted EBITDA is the score.

2026 Dental Practice Valuation Multiples by Practice Type and Size

The dental M&A market in 2026 has stabilized after the peak of 2021–2022. Transaction volume has not returned to those record levels, but well-capitalized buyers — DSOs, private equity platforms, and strategic acquirers — continue to compete aggressively for high-quality practices.

The table below reflects current dental practice valuation multiples in 2026 for general dentistry and specialty practices.

For context: in 2024, closed transactions for larger dental groups ranged from 6.75x to 11.25x adjusted EBITDA, with the strongest practices reaching up to 375% of collections on an equivalent basis. Partnership values for single-office general practices ranged from roughly $2.75 million to $62 million — a spread that reflects exactly how much deal structure, buyer competition, and practice quality matter.

The 6 Factors That Move Your Dental EBITDA Multiple

Within any size category, the spread between the low and high end of the valuation range is meaningful — often 40% to 60% of total enterprise value. These six factors determine where your practice falls.

1. Owner Dependency

This is the single largest discount factor in dental practice valuation multiples. If patients come to see you specifically — if your name is the brand, if production collapses when you take a two-week vacation — buyers price that risk into the multiple. Heavily. The fix is associate coverage: one or more producing associates who are not the owner and who patients are comfortable seeing. Practices with durable associate coverage consistently achieve multiples one to three turns higher than comparable solo-doctor practices.

2. Revenue Trajectory

Buyers are buying the future, not the past. A practice growing 8% to 10% annually commands a meaningfully higher multiple than a flat practice with identical current EBITDA. Shrinking practices — even temporarily — are very difficult to sell at premium valuations. If your collections have declined over the trailing twelve months, fix that before engaging buyers, not during the process.

3. Payer Mix

Heavy Medicaid or government payer concentration reduces multiples. Buyers discount practices with significant Medicaid exposure because reimbursement rates are lower, margins are structurally thinner, and the patient base is more volatile. Fee-for-service and PPO-heavy practices consistently achieve higher dental practice sale prices on an EBITDA-multiple basis.

4. Systems and Documentation

A practice that runs on the owner's institutional knowledge is a liability to a buyer. A practice with documented SOPs, a trained office manager who can operate without the owner, and systems that do not require the owner to make every decision is an asset — and it is priced like one.

At Afinia Dental, I focused heavily on systemization — standardizing treatment planning protocols, rolling out OM-led daily huddles, and building a documented hygiene reactivation system. During diligence, the buyer's team was visibly impressed; the systems gave them the confidence and data they needed to underwrite the deal with far greater certainty and a stronger valuation.

5. Hygiene Production and Recall Rates

Hygiene is the engine of a dental practice. Buyers scrutinize three specific metrics: hygiene as a percentage of total production (healthy practices are typically 25%–35%), active patient recall rate, and reappointment percentage at the chair. Strong hygiene metrics signal a healthy, engaged patient base and predictable recurring revenue. Weak hygiene metrics signal an attrition problem that a buyer will either discount or walk away from.

6. Lease Terms and Facility Quality

Buyers need to operate your practice after close. Leases with fewer than five years remaining, unfavorable renewal terms, above-market rent, or difficult landlords create friction and reduce enterprise value. Ideally, you want at least five to seven years of lease term remaining — or a clean renewal option — before going to market.

How to Calculate Adjusted EBITDA for a Dental Practice

Most dentists have never seen their adjusted EBITDA calculated correctly. The calculation below is simplified — a formal quality-of-earnings (QoE) report will include more line items — but it captures the logic every buyer uses.

At a 6x multiple, that adjusted EBITDA is worth approximately $3.27M. At a 7x multiple — earned through associate coverage, cleaner financials, and stronger hygiene metrics — approximately $3.82M. That $550,000 spread is the return on the preparation work described in this guide, and for most practices it takes far less time and capital to achieve than owners expect. Twelve to twenty-four months of focused operational work is routinely worth high-six to low-seven figures at closing.

What Your Practice Is Worth vs. What You Actually Net

The headline valuation is not what hits your bank account. Between the enterprise value and your net proceeds, several things happen — and the dentists who are satisfied with their exits are the ones who model all of this out before signing a letter of intent.

Taxes are the first line item. A practice sale is a taxable event. The structure of the deal — asset sale vs. stock sale, allocation of purchase price across goodwill, equipment, and restrictive covenants — has significant tax implications. The difference between a well-structured and a poorly structured sale is routinely 15% to 25% of headline value. Tax planning before engaging buyers is essential, not optional.

Holdbacks and earnouts are next. 10% to 30% of the purchase price is typically held back and paid over a multi-year period contingent on post-close performance and continued employment. This is not money you have on day one.

Most PE-backed DSO transactions also include a rollover equity component — typically 20% to 40% of the deal — where you retain equity in the acquiring platform. This can be the most valuable part of the deal (a "second bite of the apple" at the next recapitalization) or it can underperform. Either way, it is not cash at close.

A competent sell-side advisor typically charges 3% to 5% of transaction value. It is money well spent — advisors who run competitive processes consistently achieve higher prices than owners negotiating directly with a single buyer — but it is a real line item.

Most PE-backed DSOs also require a 3- to 5-year post-close employment commitment. During this period, your compensation is typically a market-rate associate wage, not the owner's draw you were accustomed to. Model this carefully. A $5M sale with five years of $300K/year employment looks very different from a $5M sale with two years of employment — and both look different from $5M cash at close.

The dentists who are genuinely satisfied with their PE exits are the ones who understood all of these factors before the LOI was signed. The ones who are not — and there are many — were surprised by them at closing.

Get a Realistic Valuation Assessment

If you own a practice doing $1M to $10M in collections and are considering a sale in the next one to five years, the most valuable thing you can do right now is: calculate your adjusted EBITDA correctly, identify the two or three factors from the list above that are discounting your multiple, and start addressing them methodically over 12 to 24 months.

The preparation work is not complicated. But it takes time, and practices that go to market unprepared consistently leave meaningful money on the table. If you want a realistic assessment of what your practice is actually worth and whether now is the right time, [book a complimentary valuation consultation](/contact). I have been through this process as an operator — I built and sold Afinia Dental Group — and I understand what DSO and PE buyers are actually underwriting, because I have been on both sides of the table.